突变型纤蛋白-3导致蛋白聚糖积聚并损害跨布鲁赫膜扩散
研究携带R345W突变的Efemp1ki/ki小鼠及Efemp1-/-小鼠,观察布鲁赫膜蛋白聚糖含量与扩散功能变化。结果显示突变型纤蛋白-3引起蛋白聚糖积聚、MMP-2和MMP-9减少、TIMP-3增加,并损害跨布鲁赫膜扩散;而纤蛋白-3缺失则改变蛋白聚糖大小及MMP分布,并增强扩散。
要点
- Efemp1ki/ki小鼠布鲁赫膜中HSPG和C/DSPG明显增加,MMP-2和MMP-9减少,TIMP-3增加。
- Efemp1ki/ki小鼠跨布鲁赫膜扩散受损。
- Efemp1-/-小鼠布鲁赫膜蛋白聚糖总量无显著差异但体积增大,MMP-2、MMP-3和TIMP-3水平与野生型相似但弥漫分布于RPE细胞。
核心结论
- 突变型纤蛋白-3导致蛋白聚糖积聚、MMP-2和MMP-9减少、TIMP-3增加,并损害跨布鲁赫膜扩散。
- 纤蛋白-3缺失导致蛋白聚糖大小改变、MMP-2、MMP-9和TIMP-3分布改变,并增强跨布鲁赫膜扩散。
研究设计与样本
- 研究使用携带R345W突变的Efemp1ki/ki小鼠和Efemp1-/-小鼠,以Efemp1+/+小鼠为对照。
- 方法包括Cupromeronic Blue染色蛋白聚糖、酶处理显示HSPG和C/DSPG分布、DMMB测定sGAGs、免疫荧光及Image J定量MMP-2、MMP-9和TIMP-3,以及改良Ussing室扩散实验结合凝胶排阻色谱定量。
主要发现
- Efemp1ki/ki小鼠布鲁赫膜中HSPGs和C/DSPGs明显增加,MMP-2和MMP-9减少,TIMP-3增加。
- Efemp1ki/ki小鼠跨布鲁赫膜扩散受损。
- Efemp1-/-小鼠布鲁赫膜蛋白聚糖量与Efemp1+/+小鼠无显著差异,但蛋白聚糖体积明显增大。
- Efemp1-/-小鼠MMP-2、MMP-3和TIMP-3水平与Efemp1+/+小鼠相似,但弥漫分布于RPE细胞内而非布鲁赫膜。
- Efemp1-/-小鼠跨布鲁赫膜扩散增强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The mutation R345W in EFEMP1 (fibulin-3) causes macular degeneration. This study sought to determine whether proteoglycan content and diffusion across Bruch's membrane are altered in Efemp1ki/ki mice carrying this mutation or in Efemp1-/- mice. METHODS: Proteoglycans in mouse Bruch's membranes were stained with Cupromeronic Blue (CB). Heparan sulfated proteoglycan (HSPG) and chondroitin/dermatan sulfate proteoglycan (C/DSPG) distributions were visualized following treatments with chondroitinase ABC (C-ABC) or nitrous acid. Total sulfated glycosaminoglycans (sGAGs) in Bruch's membrane/choroid (BrM/Ch) were measured with dimethylmethylene blue (DMMB). Matrix metalloprotease (MMP)-2, MMP-9, and tissue inhibitor of metalloproteinase (TIMP)-3 were examined by immunofluorescence and quantified using Image J. Molecules with different Stokes radius (Rs) were allowed simultaneously to diffuse through mouse BrM/Ch mounted in a modified Ussing chamber. Samples were quantified using gel exclusion chromatography. RESULTS: HSPGs and C/DSPGs were markedly increased in Efemp1ki/ki Bruch's membrane, and MMP-2 and MMP-9 were decreased, but TIMP-3 was increased. Diffusion across Efemp1ki/ki Bruch's membrane was impaired. In contrast, the proteoglycan amount in Efemp1-/- Bruch's membrane was not significantly different, but the size of proteoglycans was much larger. MMP-2, MMP-3, and TIMP-3 levels were similar to that of Efemp1+/+ mice, but they were localized diffusely in retinal pigment epithelium (RPE) cells instead of Bruch's membrane. Diffusion across Efemp1-/- Bruch's membrane was enhanced. CONCLUSIONS: Mutant fibulin-3 causes proteoglycan accumulation, reduction of MMP-2 and MMP-9, but increase of TIMP-3, and impairs diffusion across Bruch's membrane. Fibulin-3 ablation results in altered sizes of proteoglycans, altered distributions of MMP-2, MMP-9, and TIMP-3, and enhances diffusion across Bruch's membrane.
引用
- Zayas-Santiago A, Cross SD, Stanton JB, et al. Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane. Invest Ophthalmol Vis Sci. 2017. PMID: 28622396. doi:10.1167/iovs.17-21720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。